Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program

Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program

Background: Data on the epidemiology and treatment of atrial fibrillation in the Africa/Middle East region are limited, and the use of novel oral anticoagulants and their effectiveness in real-world clinical practice has not been evaluated. Methods and Results: This study used prospectively collecte...

Full description

Bibliographic Details
Main Authors: Rabih R. Azar, Hany I. Ragy, Omer Kozan, Maurice El Khuri, Nooshin Bazergani, Sabrina Marler, Christine Teutsch, Mohamed Ibrahim, Gregory Y.H. Lip, Menno V. Huisman
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Anticoagulant
Atrial fibrillation
NOACs
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906721000518

Similar Items

Similar Items